Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.37
-0.4%
$0.47
$0.36
▼
$4.00
$20.73M-0.8411,616 shs153,382 shs
HeartSciences Inc. stock logo
HSCS
HeartSciences
$4.18
+3.2%
$3.11
$1.63
▼
$5.25
$19.62M1.85154,490 shs72,922 shs
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$1.62
+1.6%
$2.45
$1.56
▼
$42.00
$5.45M0.45101,315 shs320,564 shs
Lifeward Ltd. stock logo
LFWD
Lifeward
$6.70
-3.1%
$7.23
$4.14
▼
$10.20
$19.57M0.394,203 shs4,465 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-0.35%-5.73%-22.00%-49.08%-77.85%
HeartSciences Inc. stock logo
HSCS
HeartSciences
+3.21%-7.52%+32.70%+49.82%+20.11%
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
+1.57%-13.64%-29.17%-69.87%-94.70%
Lifeward Ltd. stock logo
LFWD
Lifeward
-3.05%-5.31%-12.43%-16.47%-21.55%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HeartBeam, Inc. stock logo
BEAT
HeartBeam
$0.37
-0.4%
$0.47
$0.36
▼
$4.00
$20.73M-0.8411,616 shs153,382 shs
HeartSciences Inc. stock logo
HSCS
HeartSciences
$4.18
+3.2%
$3.11
$1.63
▼
$5.25
$19.62M1.85154,490 shs72,922 shs
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$1.62
+1.6%
$2.45
$1.56
▼
$42.00
$5.45M0.45101,315 shs320,564 shs
Lifeward Ltd. stock logo
LFWD
Lifeward
$6.70
-3.1%
$7.23
$4.14
▼
$10.20
$19.57M0.394,203 shs4,465 shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-0.35%-5.73%-22.00%-49.08%-77.85%
HeartSciences Inc. stock logo
HSCS
HeartSciences
+3.21%-7.52%+32.70%+49.82%+20.11%
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
+1.57%-13.64%-29.17%-69.87%-94.70%
Lifeward Ltd. stock logo
LFWD
Lifeward
-3.05%-5.31%-12.43%-16.47%-21.55%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HeartBeam, Inc. stock logo
BEAT
HeartBeam
2.56
Moderate Buy$4.00991.11% Upside
HeartSciences Inc. stock logo
HSCS
HeartSciences
2.00
Hold$8.0091.39% Upside
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
2.20
Hold$52.503,150.77% Upside
Lifeward Ltd. stock logo
LFWD
Lifeward
2.25
Hold$10.0049.28% Upside

Current Analyst Ratings Breakdown

Latest ICCM, BEAT, LFWD, and HSCS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/29/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
Reiterated RatingSell (E+)
9/24/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
DowngradeSell (D-) ➝ Sell (E+)
9/22/2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
DowngradeBuy ➝ Neutral
9/21/2026
HeartSciences Inc. stock logo
HSCS
HeartSciences
Reiterated RatingSell (E+)
9/2/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
UpgradeSell (E+) ➝ Sell (D-)
8/21/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
Reiterated RatingBuy
8/21/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
Reiterated RatingBuy$10.00
8/18/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
DowngradeSell (D-) ➝ Sell (E+)
8/14/2026
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
DowngradeHold ➝ Strong Sell
8/3/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
UpgradeSell (E+) ➝ Sell (D-)
7/27/2026
Lifeward Ltd. stock logo
LFWD
Lifeward
UpgradeStrong Sell ➝ Hold
(Data available from 10/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/A$0.06 per shareN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/A($0.42) per shareN/A
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
$3.38M1.64N/AN/A$3.72 per share0.43
Lifeward Ltd. stock logo
LFWD
Lifeward
$22.03M0.86N/AN/A$5.52 per share1.21
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$21.01M-$0.51N/AN/AN/AN/A-686.78%-348.65%11/12/2026 (Estimated)
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$9.14M-$3.22N/AN/AN/AN/A-816.90%-181.97%N/A
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
-$15.06M-$8.52N/AN/AN/A-427.67%-174.26%-112.58%11/18/2026 (Estimated)
Lifeward Ltd. stock logo
LFWD
Lifeward
-$19.91M-$16.82N/AN/AN/A-141.28%-235.86%-81.72%11/13/2026 (Estimated)

Latest ICCM, BEAT, LFWD, and HSCS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/14/2026Q1 2027
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$0.72-$0.86-$0.14-$0.86$0.10 million$0.00 million
8/15/2026Q2 2026
Lifeward Ltd. stock logo
LFWD
Lifeward
-$1.39-$1.46-$0.07-$4.12$6.53 million$6.62 million
8/13/2026Q2 2026
HeartBeam, Inc. stock logo
BEAT
HeartBeam
-$0.0860-$0.10-$0.0140-$0.10$0.15 millionN/A
7/23/2026Q4 2026
HeartSciences Inc. stock logo
HSCS
HeartSciences
-$0.66-$0.88-$0.22-$0.87$0.05 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/AN/AN/AN/AN/A
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/AN/AN/AN/AN/A
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
N/AN/AN/AN/AN/A
Lifeward Ltd. stock logo
LFWD
Lifeward
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HeartBeam, Inc. stock logo
BEAT
HeartBeam
N/A
3.66
3.61
HeartSciences Inc. stock logo
HSCS
HeartSciences
N/A
0.14
0.07
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
N/A
2.88
2.44
Lifeward Ltd. stock logo
LFWD
Lifeward
0.70
2.33
1.77

Institutional Ownership

CompanyInstitutional Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
7.77%
HeartSciences Inc. stock logo
HSCS
HeartSciences
17.24%
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
0.62%
Lifeward Ltd. stock logo
LFWD
Lifeward
26.76%

Insider Ownership

CompanyInsider Ownership
HeartBeam, Inc. stock logo
BEAT
HeartBeam
17.95%
HeartSciences Inc. stock logo
HSCS
HeartSciences
4.90%
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
2.44%
Lifeward Ltd. stock logo
LFWD
Lifeward
1.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
HeartBeam, Inc. stock logo
BEAT
HeartBeam
1,70056.35 million46.23 millionNot Optionable
HeartSciences Inc. stock logo
HSCS
HeartSciences
144.84 million4.61 millionNot Optionable
IceCure Medical Ltd. stock logo
ICCM
IceCure Medical
663.43 million3.34 millionNot Optionable
Lifeward Ltd. stock logo
LFWD
Lifeward
812.83 million2.79 millionOptionable

Recent News About These Companies

Lifeward (NASDAQ:LFWD) vs. Bioventus (NASDAQ:BVS) Head to Head Contrast
Lifeward Sets Timeline for 2026 Shareholder Meeting
Lifeward Out With Q2 Numbers

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
HeartBeam stock logo

HeartBeam NASDAQ:BEAT

$0.37 0.00 (-0.35%)
Closing price 09/30/2026 04:00 PM Eastern
Extended Trading
$0.38 +0.02 (+4.20%)
As of 07:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

HeartSciences stock logo

HeartSciences NASDAQ:HSCS

$4.18 +0.13 (+3.21%)
Closing price 09/30/2026 04:00 PM Eastern
Extended Trading
$4.47 +0.29 (+7.03%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

IceCure Medical stock logo

IceCure Medical NASDAQ:ICCM

$1.62 +0.03 (+1.57%)
Closing price 09/30/2026 04:00 PM Eastern
Extended Trading
$1.67 +0.05 (+3.22%)
As of 08:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Lifeward stock logo

Lifeward NASDAQ:LFWD

$6.70 -0.21 (-3.05%)
Closing price 09/30/2026 03:58 PM Eastern
Extended Trading
$6.70 0.00 (0.00%)
As of 09/30/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.